-
Histopathology Based AI Model Predicts Anti-Angiogenic Therapy Response in Renal Cancer Clinical Trial
Authors:
Jay Jasti,
Hua Zhong,
Vandana Panwar,
Vipul Jarmale,
Jeffrey Miyata,
Deyssy Carrillo,
Alana Christie,
Dinesh Rakheja,
Zora Modrusan,
Edward Ernest Kadel III,
Niha Beig,
Mahrukh Huseni,
James Brugarolas,
Payal Kapur,
Satwik Rajaram
Abstract:
Predictive biomarkers of treatment response are lacking for metastatic clear cell renal cell carcinoma (ccRCC), a tumor type that is treated with angiogenesis inhibitors, immune checkpoint inhibitors, mTOR inhibitors and a HIF2 inhibitor. The Angioscore, an RNA-based quantification of angiogenesis, is arguably the best candidate to predict anti-angiogenic (AA) response. However, the clinical adopt…
▽ More
Predictive biomarkers of treatment response are lacking for metastatic clear cell renal cell carcinoma (ccRCC), a tumor type that is treated with angiogenesis inhibitors, immune checkpoint inhibitors, mTOR inhibitors and a HIF2 inhibitor. The Angioscore, an RNA-based quantification of angiogenesis, is arguably the best candidate to predict anti-angiogenic (AA) response. However, the clinical adoption of transcriptomic assays faces several challenges including standardization, time delay, and high cost. Further, ccRCC tumors are highly heterogenous, and sampling multiple areas for sequencing is impractical. Here we present a novel deep learning (DL) approach to predict the Angioscore from ubiquitous histopathology slides. To overcome the lack of interpretability, one of the biggest limitations of typical DL models, our model produces a visual vascular network which is the basis of the model's prediction. To test its reliability, we applied this model to multiple cohorts including a clinical trial dataset. Our model accurately predicts the RNA-based Angioscore on multiple independent cohorts (spearman correlations of 0.77 and 0.73). Further, the predictions help unravel meaningful biology such as association of angiogenesis with grade, stage, and driver mutation status. Finally, we find our model can predict response to AA therapy, in both a real-world cohort and the IMmotion150 clinical trial. The predictive power of our model vastly exceeds that of CD31, a marker of vasculature, and nearly rivals the performance (c-index 0.66 vs 0.67) of the ground truth RNA-based Angioscore at a fraction of the cost. By providing a robust yet interpretable prediction of the Angioscore from histopathology slides alone, our approach offers insights into angiogenesis biology and AA treatment response.
△ Less
Submitted 28 May, 2024;
originally announced May 2024.
-
PTransIPs: Identification of phosphorylation sites enhanced by protein PLM embeddings
Authors:
Ziyang Xu,
Haitian Zhong,
Bingrui He,
Xueying Wang,
Tianchi Lu
Abstract:
Phosphorylation is pivotal in numerous fundamental cellular processes and plays a significant role in the onset and progression of various diseases. The accurate identification of these phosphorylation sites is crucial for unraveling the molecular mechanisms within cells and during viral infections, potentially leading to the discovery of novel therapeutic targets. In this study, we develop PTrans…
▽ More
Phosphorylation is pivotal in numerous fundamental cellular processes and plays a significant role in the onset and progression of various diseases. The accurate identification of these phosphorylation sites is crucial for unraveling the molecular mechanisms within cells and during viral infections, potentially leading to the discovery of novel therapeutic targets. In this study, we develop PTransIPs, a new deep learning framework for the identification of phosphorylation sites. Independent testing results demonstrate that PTransIPs outperforms existing state-of-the-art (SOTA) methods, achieving AUCs of 0.9232 and 0.9660 for the identification of phosphorylated S/T and Y sites, respectively. PTransIPs contributes from three aspects. 1) PTransIPs is the first to apply protein pre-trained language model (PLM) embeddings to this task. It utilizes ProtTrans and EMBER2 to extract sequence and structure embeddings, respectively, as additional inputs into the model, effectively addressing issues of dataset size and overfitting, thus enhancing model performance; 2) PTransIPs is based on Transformer architecture, optimized through the integration of convolutional neural networks and TIM loss function, providing practical insights for model design and training; 3) The encoding of amino acids in PTransIPs enables it to serve as a universal framework for other peptide bioactivity tasks, with its excellent performance shown in extended experiments of this paper. Our code, data and models are publicly available at https://github.com/StatXzy7/PTransIPs.
△ Less
Submitted 13 March, 2024; v1 submitted 8 August, 2023;
originally announced August 2023.
-
Inactivated COVID-19 Vaccination did not affect In vitro fertilization (IVF) / Intra-Cytoplasmic Sperm Injection (ICSI) cycle outcomes
Authors:
Qi Wan,
Ying Ling Yao,
XingYu Lv,
Li Hong Geng,
Yue Wang,
Enoch Appiah Adu-Gyamfi,
Xue Jiao Wang,
Yue Qian,
Juan Yang,
Ming Xing Chend,
Zhao Hui Zhong,
Yuan Li,
Yu Bin Ding
Abstract:
Background: The objective of this study is to evaluate the impact of COVID-19 inactivated vaccine administration on the outcomes of in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) cycles in infertile couples in China. Methods: We collected data from the CYART prospective cohort, which included couples undergoing IVF treatment from January 2021 to September 2022 at Sichuan…
▽ More
Background: The objective of this study is to evaluate the impact of COVID-19 inactivated vaccine administration on the outcomes of in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) cycles in infertile couples in China. Methods: We collected data from the CYART prospective cohort, which included couples undergoing IVF treatment from January 2021 to September 2022 at Sichuan **xin Xinan Women & Children's Hospital. Based on whether they received vaccination before ovarian stimulation, the couples were divided into the vaccination group and the non-vaccination group. We compared the laboratory parameters and pregnancy outcomes between the two groups. Findings: After performing propensity score matching (PSM), the analysis demonstrated similar clinical pregnancy rates, biochemical pregnancy and ongoing pregnancy rates between vaccinated and unvaccinated women. No significant disparities were found in terms of embryo development and laboratory parameters among the groups. Moreover, male vaccination had no impact on patient performance or pregnancy outcomes in assisted reproductive technology treatments. Additionally, there were no significant differences observed in the effects of vaccination on embryo development and pregnancy outcomes among couples undergoing ART. Interpretation: The findings suggest that COVID-19 vaccination did not have a significant effect on patients undergoing IVF/ICSI with fresh embryo transfer. Therefore, it is recommended that couples should receive COVID-19 vaccination as scheduled to help mitigate the COVID-19 pandemic.
△ Less
Submitted 13 June, 2023;
originally announced June 2023.